Graft-Versus-Host Disease-Free, Relapse-Free Survival in Allogeneic Stem Cell Transplantation for Adult T-Cell Leukemia/Lymphoma Provides a Novel Donor Selection Paradigm

被引：0

作者：

Muranushi, Hiroyuki ^{[1
]}

Shindo, Takero ^{[1
]}

Hishizawa, Masakatsu ^{[1
]}

Tokunaga, Masahito ^{[2
]}

Wake, Atsushi ^{[3
]}

Nakano, Nobuaki ^{[4
]}

Eto, Tetsuya ^{[5
]}

Hidaka, Michihiro ^{[6
]}

Choi, Ilseung ^{[6
]}

Miyamoto, Toshihiro ^{[7
]}

Uchida, Naoyuki ^{[8
]}

Moriuchi, Yukiyoshi ^{[9
]}

Miyazaki, Yasuhiko ^{[10
]}

Fukuda, Takahiro ^{[11
]}

Ichinohe, Tatsuo ^{[12
]}

Atsuta, Yoshiko ^{[13
,14
]}

Kato, Koji ^{[15
]}

机构：

[1] Kyoto Univ, Grad Sch Med, Dept Hematol & Oncol, Kyoto, Japan

[2] Imamura Gen Hosp, Dept Hematol, Kagoshima, Japan

[3] Toranomon Gen Hosp, Dept Hematol, Tokyo, Japan

[4] Imamura Gen Hosp, Dept Hematol, Kagoshima, Japan

[5] Hamanomachi Hosp, Dept Hematol, Fukuoka, Japan

[6] Natl Hosp Org Kumamoto Med Ctr, Dept Hematol, Kumamoto, Japan

[7] Kyushu Univ, Grad Sch Med Sci, Fukuoka, Japan

[8] Toranomon Gen Hosp, Dept Hematol, Federat Natl Publ Serv Personnel Mutual Aid Assoc, Tokyo, Japan

[9] Sasebo City Gen Hosp, Dept Hematol, Sasebo, Japan

[10] Oita Prefectural Hosp, Dept Hematol, Oita, Japan

[11] Natl Canc Ctr, Dept Hematopoiet Stem Cell Transplantat, Tokyo, Japan

[12] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Hematol & Oncol, Hiroshima, Japan

[13] Nagoya Univ, Dept Healthcare Adm, Nagoya, Aichi, Japan

[14] Japanese Data Ctr Hematopoiet Cell Transplantat, Nagoya, Aichi, Japan

[15] Kyushu Univ, Grad Sch Med Sci, Dept Med & Biosyst Sci, Fukuoka, Japan

来源：

BLOOD | 2019年 / 134卷

关键词：

D O I：

10.1182/blood-2019-123318

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

2008

引用

页数：3

共 50 条

[1] Graft-versus-Host Disease-Free, Relapse-Free Survival after Allogeneic Stem Cell Transplantation for Myelodysplastic Syndrome
Park, Sung-Soo
Jeon, Young-Woo
Min, Gi June
Park, Silvia
Yahng, Seung-Ah
Yoon, Jae-Ho
Shin, Seung-Hwan
Lee, Sung-Eun
Cho, Byung-Sik
Eom, Ki-Seong
Lee, Seok
Kim, Hee-Je
Min, Chang-Ki
Cho, Seok-Goo
Lee, Jong Wook
Kim, Yoo-Jin
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (01) : 63 - 72
[2] Prognostic Factors on the Graft-versus-Host Disease-Free and Relapse-Free Survival after Adult Allogeneic Hematopoietic Stem Cell Transplantation
Liu, Yao-Chung
Chien, Sheng-Hsuan
Fan, Nai-Wen
Hu, Ming-Hung
Gau, Jyh-Pyng
Liu, Chia-Jen
Yu, Yuan-Bin
Hsiao, Liang-Tsai
Chiou, Tzeon-Jye
Tzeng, Cheng-Hwai
Chen, Po-Min
Liu, Jin-Hwang
STEM CELLS INTERNATIONAL, 2016, 2016
[3] Partial T-cell depletion improves the composite endpoint graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic stem cell transplantation
Simonetta, Federico
Masouridi-Levrat, Stavroula
Beauverd, Yan
Tsopra, Olga
Tirefort, Yordanka
Koutsi, Aikaterini
Stephan, Caroline
Polchlopek-Blasiak, Karolina
Pradier, Amandine
Dantin, Carole
Ansari, Marc
Roosnek, Eddy
Chalandon, Yves
LEUKEMIA & LYMPHOMA, 2018, 59 (03) : 590 - 600
[4] T-cell depletion improves the composite end point graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic stem cell transplantation
Simonetta, F.
Masouridi-Levrat, S.
Beauverd, Y.
Tsopra, O.
Tirefort, Y.
Stephan, C.
Polchlopek, K.
Favale, R.
Dantin, C.
Ansari, M.
Roosnek, E.
Chalandon, Y.
BONE MARROW TRANSPLANTATION, 2016, 51 : S223 - S224
[5] T-Cell Depletion Improves the Composite End Point Graft-Versus-Host Disease-Free, Relapse-Free Survival after Allogeneic Hematopoietic Stem Cell Transplantation
Simonetta, Federico
Masouridi-Levrat, Stavroula
Beauverd, Yen
Tsopra, Olga
Tirefort, Yordanka
Stephan, Caroline
Polchlopek, Karolina
Favale, Riccardo
Dentin, Carole
Ansari, Marc
Roosnek, Eddy
Chalandon, Yves
BLOOD, 2015, 126 (23)
[6] Prognostic factors on graft-versus-host disease-free and relapse-free survival after allogeneic hematopoietic stem cell transplantation for adults with acute leukemia
Tan, Jie
Wang, Ya
Yu, Si-Jian
Ma, Yong-Yong
Lei, Hu-Yi
Liu, Qi-Fa
LEUKEMIA RESEARCH, 2017, 59 : 1 - 7
[7] Composite end point of graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic cell transplantation
Holtan, Shernan G.
DeFor, Todd E.
Lazaryan, Aleksandr
Bejanyan, Nelli
Arora, Mukta
Brunstein, Claudio G.
Blazer, Bruce R.
MacMillan, Margaret L.
Weisdorf, Daniel J.
BLOOD, 2015, 125 (08) : 1333 - 1338
[8] Graft-versus-host disease-free, relapse-free, second transplant-free survival in allogeneic hematopoietic cell transplantation for genetic disorders
Kawaguchi, Koji
Umeda, Katsutsugu
Miyamoto, Satoshi
Yoshida, Nao
Yabe, Hiromasa
Koike, Takashi
Kajiwara, Michiko
Kawaguchi, Hiroshi
Takahashi, Yoshiyuki
Ishimura, Masataka
Sakaguchi, Hirotoshi
Hama, Asahito
Cho, Yuko
Sato, Maho
Kato, Keisuke
Sato, Atsushi
Kato, Koji
Tabuchi, Ken
Atsuta, Yoshiko
Imai, Kohsuke
BONE MARROW TRANSPLANTATION, 2023, 58 (05) : 600 - 602
[9] Graft-versus-host disease-free, relapse-free, second transplant-free survival in allogeneic hematopoietic cell transplantation for genetic disorders
Koji Kawaguchi
Katsutsugu Umeda
Satoshi Miyamoto
Nao Yoshida
Hiromasa Yabe
Takashi Koike
Michiko Kajiwara
Hiroshi Kawaguchi
Yoshiyuki Takahashi
Masataka Ishimura
Hirotoshi Sakaguchi
Asahito Hama
Yuko Cho
Maho Sato
Keisuke Kato
Atsushi Sato
Koji Kato
Ken Tabuchi
Yoshiko Atsuta
Kohsuke Imai
Bone Marrow Transplantation, 2023, 58 : 600 - 602
[10] FACTORS PREDICTING GRAFT-VERSUS-HOST DISEASE-FREE, RELAPSE-FREE SURVIVAL AND OUTCOMES AFTER REDUCED INTENSITY ALLOGENEIC STEM CELL TRANSPLANTATION FOR ACUTE LEUKEMIA OR MYELODYSPLASTIC SYNDROMES
Kanamori, H.
Aoki, J.
Negoro, A.
Koyama, S.
Tachibana, T.
Nakajima, H.
Tanaka, M.
HAEMATOLOGICA, 2017, 102 : 860 - 860

← 1 2 3 4 5 →